Central nervous system metastases in patients with high-risk breast carcinoma after multimodality treatment

Cancer

Volumn 101, Issue 8, 2004, Pages 1760-1766

  Gonzalez Angulo, Ana M ^a   Cristofanilli, Massimo ^a   Strom, Eric A ^a   Buzdar, Aman U ^a   Kau, Shu Wan ^a   Broglio, Kristine R ^a   Smith, Terry L ^a   Hortobagyi, Gabriel N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Central nervous system metastases; Inflammatory breast carcinoma; Locally advanced breast carcinoma; Primary chemotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; PACLITAXEL; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; BREAST CARCINOMA; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM METASTASIS; HIGH RISK PATIENT; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; TUMOR CLASSIFICATION; TUMOR VOLUME; UNITED STATES;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA, DUCTAL; CARCINOMA, LOBULAR; CENTRAL NERVOUS SYSTEM NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INCIDENCE; LYMPH NODES; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 4744358184     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20530     Document Type: Article

References (31)

1. DiStefano A, Yap HY, Hortobagyi GN, Blumenschein GR. The natural history of breast cancer patients with brain metastases. Cancer. 1979;44:1913-1918.
2. Tsukada Y, Fouad A, Pickren JW, Lane WW. Central nervous system metastasis from breast carcinoma. Autopsy study. Cancer. 1983;52:2349-2354.
3. Ahmann FR, Jones SE, Moon TE. The effect of prior adjuvant chemotherapy on survival in metastatic breast cancer. J Surg Oncol. 1988;37:116-122.
4. Crivellari D, Pagani O, Veronesi A, et al. High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel. Ann Oncol. 2001;12:353-356.
5. Kosmas C, Malamos NA, Tsavaris NB, et al. Leptomeningeal carcinomatosis after major remission to taxane-based front-line therapy in patients with advanced breast cancer. J Neurooncol. 2002;56:265-273.
6. Chock J, Domchek S, Burstein H, et al. Central nervous system (CNS) metastases in women who receive trastuzumab for metastatic breast cancer (MBC) [abstract]. Proc Am Soc Clin Oncol. 2002;21:55a.
7. Freilich RJ, Seidman AD, DeAngelis LM. Central nervous system progression of metastatic breast cancer in patients treated with paclitaxel. Cancer. 1995;76:232-236.
8. Seidman AD, Fornier M, Esteva FJ, et al. Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification. J Clin Oncol. 2001;19:2587-2595.
9. Chang EL, Lo S. Diagnosis and management of central nervous system metastases from breast cancer. Oncologist. 2003;8:398-410.
10. Booser D, Frye D, Singletary SE. Response to induction chemotherapy for breast cancer: a prospective multimodality treatment program [abstract]. Proc Am Soc Clin Oncol. 1992;11:82.
11. Dhingra K, Esparza-Guerra L, Valero V, et al. A Phase III randomized trial of dose-intensive neoadjuvant 5FU, doxorubicin, cyclophosphamide (FAC) with G-CSF (filgrastim) in locally advanced breast cancer (LABC). Efficacy and safety data [abstract]. Proc Am Soc Clin Oncol 1999;18:74a.
12. Hortobagyi GN, Holmes FA, Frye D, et al. Comparison of two adjuvant chemotherapy programs for locally advanced breast cancer: a prospective randomized trial [abstract]. Proc Am Soc Clin Oncol. 1990;9:21.
13. [No author listed]. The World Health Organization histological typing of breast tumors-second edition. Am J Clin Pathol. 1982;78:806-816.
14. Black MM, Speer FD. Nuclear structure in cancer tissues. Surg Gynecol Obstet. 1957;105:97-102.
15. Posner JB, Chernik NL. Intracranial metastases from systemic cancer. Adv Neurol. 1978;19:579-592.
16. Boogerd W, Vos VW, Hart AA, Baris G. Brain metastases in breast cancer; natural history, prognostic factors and outcome. J Neurooncol. 1993;15:165-174.
17. Stewart JF, King RJ, Sexton SA, Millis RR, Rubens RD, Hayward JL. Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancer. Eur J Cancer. 1981;17:449-453.
18. Clark GM, Sledge GW Jr., Osborne CK, McGuire WL. Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients. J Clin Oncol. 1987;5:55-61.
19. Lee YT. Breast carcinoma: pattern of recurrence and metastasis after mastectomy. Am J Clin Oncol. 1984;7:443-449.
20. Paterson AH, Agarwal M, Lees A, Hanson J, Szafran O. Brain metastases in breast cancer patients receiving adjuvant chemotherapy. Cancer. 1982;49:651-654.
21. Chia S, Speers C, Kang A, et al. The impact of new chemotherapeutic and hormonal agents on the survival of women with metastatic breast cancer (MBC) in a population based cohort [abstract]. Proc Am Soc Clin Oncol. 2003;22:6.
22. Lower EE, Blau R, Bismayer J, et al. Increased brain metastasis detected in metastatic breast cancer patients receiving herceptin [abstract]. Breast Cancer Res Treat. 2001;69:271.
23. Pansegrau G, Lohrisch C, Bajdik C, et al. A prognostic model to predict the risk of developing brain metastasis in patients treated with trastuzumab for HER-2 positive metastatic breast cancer [abstract]. Breast Cancer Res Treat. 2003;82:271.
24. Viadana E, Bross ID, Pickren JW. An autopsy study of some routes of dissemination of cancer of the breast. Br J Cancer. 1973;27:336-340.
25. Mintz AH, Kestle J, Rathbone MP, et al. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer. 1996;78:1470-1476.
26. Giordano SH, Buzdar AU, Smith TL, Kau SW, Yang Y, Hortobagyi GN. Is breast cancer survival improving? Cancer. 2004;100:44-52.
27. Zimm S, Wampler GL, Stablein D, Hazra T, Young HF. Intracerebral metastases in solid-tumor patients: natural history and results of treatment. Cancer. 1981;48:384-394.
28. Hagemeister FB Jr., Buzdar AU, Luna MA, Blumenschein GR. Causes of death in breast cancer: a clinicopathologic study. Cancer. 1980;46:162-167.
29. Fokstuen T, Wilking N, Rutqvist LE, et al. Radiation therapy in the management of brain metastases from breast cancer. Breast Cancer Res Treat. 2000;62:211-216.
30. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain [see comments]. N Engl J Med. 1990;322:494-500.
31. Vecht CJ, Haaxma-Reiche H, Noordijk EM, et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol. 1993;33:583-590.